A drug with the SMILES CN1Cc2c(N3CCOCC3)nc(SCCC#N)c(C#N)c2CC1(C)C has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -2.454%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CN1Cc2c(N3CCOCC3)nc(SCCC#N)c(C#N)c2CC1(C)C
CN1Cc2c(N3CCOCC3)nc(SCCC#N)c(C#N)c2CC1(C)C
3-(2-cyanoethylsulfanyl)-6,6,7-trimethyl-1-morpholin-4-yl-5,8-dihydro-2,7-naphthyridine-4-carbonitrile